Sugi Predict

Sugi Predict / Compounds / SCHEMBL3663321

SCHEMBL3663321

SCHEMBL3663321

CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)OC(C)(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.68
▸ CYP3A4 P08684 3/20 0.68
▸ ALOX15 P16050 3/20 0.68
▸ HSD17B10 Q99714 3/20 0.68
▸ TDP1 Q9NUW8 3/20 0.68
▸ TSHR P16473 2/20 0.68
▸ F7 P08709 6/20 0.61
▸ F3 P13726 6/20 0.61
▸ CYP19A1 P11511 4/20 0.61
▸ PPARG P37231 4/20 0.61
▸ PPARD Q03181 4/20 0.61
▸ PPARA Q07869 4/20 0.61
▸ OXER1 Q8TDS5 3/20 0.61
▸ PTGS1 P23219 3/20 0.61
▸ KDM4E B2RXH2 3/20 0.61
▸ MAPT P10636 2/20 0.61
▸ NR1I2 O75469 2/20 0.61
▸ PTGS2 P35354 2/20 0.61
▸ KMT2A Q03164 2/20 0.61
▸ FFAR1 O14842 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12614586 0.95 ALDH1A1 (0.59) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL29066142 0.95 ALDH1A1 (0.59) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL12614584 0.95 ALDH1A1 (0.59) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL18250207 0.94 ADORA3 (0.66) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL16577202 0.94 ADORA3 (0.66) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL28380125 0.94 ALDH1A1 (0.57) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL3661232 0.91 ALDH1A1 (0.61) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL31307952 0.88 HSD17B10 (0.49) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL17612122 0.86 ALDH1A1 (0.53) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL3659126 0.86 MGLL (0.61) ALDH1A1CYP3A4ALOX15HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8425784-B2 Ozonolysis reactions in liquid CO2 and CO2-expanded solvents UNIVERSITY OF KANSAS (US) 2013-04-23 — — US claimed
US-11059807-B2 Amine cationic lipids and uses thereof DICERNA PHARMACEUTICALS, INC. (US) 2021-07-13 — — US disclosed
US-20190084965-A1 AMINE CATIONIC LIPIDS AND USES THEREOF NOVO NORDISK A/S (DK) 2019-03-21 — — US disclosed
EP-2209547-B1 OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS UNIV KANSAS (US) 2018-06-20 — — EP disclosed
US-20170137409-A1 Amine Cationic Lipids and Uses Thereof NOVO NORDISK A/S (DK) 2017-05-18 — — US disclosed
US-20170137409-A1 Amine Cationic Lipids and Uses Thereof NOVO NORDISK A/S (DK) 2017-05-18 — — US disclosed
US-9549983-B2 Amine cationic lipids and uses thereof DICERNA PHARMACEUTICALS, INC. (US) 2017-01-24 — — US disclosed
US-9549983-B2 Amine cationic lipids and uses thereof DICERNA PHARMACEUTICALS, INC. (US) 2017-01-24 — — US disclosed
US-20150374842-A1 PROCESS FOR FORMULATING AN ANIONIC AGENT NOVO NORDISK A/S (DK) 2015-12-31 — — US disclosed
US-20140371293-A1 Amine Cationic Lipids and Uses Thereof DICERNA PHARMACEUTICALS, INC. (US) 2014-12-18 — — US disclosed
EP-2209547-A2 OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS University Of Kansas (US) 2010-07-28 — — EP disclosed
WO-2009061806-A2 OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS UNIVERSITY OF KANSAS (US) 2009-05-14 — — WO disclosed
US-20090118498-A1 OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS ARCHER DANIELS MIDLAND COMPANY 2009-05-07 — — US disclosed
CN-1152931-C Powder paints and its preparation and use DSM 2004-06-09 — — CN disclosed
CN-1040652-C Binder composition for powder coatings, its preparation and use DSM NV (NL) 1998-11-11 — — CN disclosed
CN-1195680-A Powder paints and its preparation and use DSM NV (NL) 1998-10-14 — — CN disclosed
CN-1089290-A Binder composition for powder coatings DSM NV (NL) 1994-07-13 — — CN disclosed
EP-0326737-B1 COPPER POWDER FOR ELECTROCONDUCTIVE PAINTS AND ELECTROCONDUCTIVE PAINT COMPOSITIONS MITSUI KINZOKU KOGYO KABUSHIKI KAISHA (JP) 1992-07-08 — — EP disclosed
EP-0326737-A2 Copper powder for electroconductive paints and electroconductive paint compositions MITSUI KINZOKU KOGYO KABUSHIKI KAISHA (JP) 1989-08-09 — — EP disclosed
US-4364743-A ESTER AND MIDDLE OIL ERNER WILLIAM E 1982-12-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190084965-A1 AMINE CATIONIC LIPIDS AND USES THEREOF SGMS2, SLC43A1, SGMS1 ALDH1A1 4162/4885CYP3A4 4878/4885ALOX15 1295/4885
US-11059807-B2 Amine cationic lipids and uses thereof SGMS2, SLC43A1, SGMS1 ALDH1A1 4162/4885CYP3A4 4878/4885ALOX15 1295/4885
US-20150374842-A1 PROCESS FOR FORMULATING AN ANIONIC AGENT PHOSPHO1, POLRMT, LIPA ALDH1A1 3400/4885CYP3A4 4831/4885ALOX15 1434/4885
US-20140371293-A1 Amine Cationic Lipids and Uses Thereof SGMS2, SLC43A1, SGMS1 ALDH1A1 4162/4885CYP3A4 4878/4885ALOX15 1295/4885
US-20170137409-A1 Amine Cationic Lipids and Uses Thereof SGMS2, SLC43A1, SGMS1 ALDH1A1 4162/4885CYP3A4 4878/4885ALOX15 1295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.